Innovative Afterloader System Streamlines Brachytherapy
By MedImaging International staff writers Posted on 30 Oct 2018 |
Image: An afterloader system streamlines brachytherapy treatments (Photo courtesy of Varian).
An integrated afterloader system improves patient experience by simplifying brachytherapy treatment and providing greater workflow efficiency.
The Varian Medical Systems (Varian, Palo Alto, CA, USA) Bravos afterloader system is intended for high dose rate (HDR) brachytherapy treatment, which involves temporarily placing a small radioactive source directly into the tumor. When using an afterloader, the source can be positioned in a needle, catheter, or other tumor-specific applicator following an insertion pattern designed to create a highly conformal dose distribution within or on the surface of the patient's anatomy. Once treatment is completed, the afterloader safely retrieves the radioactive source.
To simplify this process, the Bravos afterloader features a touch screen control that provides easy access to patient treatment data, eliminating the need for the radiology technician to leave the room in order to retrieve patient and treatment information. To facilitate execution, light emitting diode (LED) green, red, and yellow lights guide clinicians instinctively through the connection process of the transfer guide tubes. The green lights signal a proper connection, while the yellow and red lights warn that there are areas in need of correction.
To help increase efficiency of the treatment process, Bravos also features a customizable pre-treatment checklist on the touchscreen. Like surgical procedures, the customizable checklist allows the clinician to set a review process, including a time-out for patient safety, and e-signatures for speed and accuracy. The Bravos afterloader system, which has been received both U.S. Food and Drug Administration (FDA) and European Union CE marking, integrates with Varian's BrachyVision for treatment planning, and also offers interoperability with the Varian ARIA oncology information system.
“After spending time in clinics around the world talking with the treatment teams, we saw the opportunity to create a system that is easy to use and creates greater efficiencies, allowing clinicians to spend more time with the patient,” said Ed Vertatschitsch, vice president of global portfolio solutions at Varian. “Bravos is a big step forward for brachytherapy treatments, and we will continue to collaborate with our partners in achieving new victories against cancer.”
The Varian Medical Systems (Varian, Palo Alto, CA, USA) Bravos afterloader system is intended for high dose rate (HDR) brachytherapy treatment, which involves temporarily placing a small radioactive source directly into the tumor. When using an afterloader, the source can be positioned in a needle, catheter, or other tumor-specific applicator following an insertion pattern designed to create a highly conformal dose distribution within or on the surface of the patient's anatomy. Once treatment is completed, the afterloader safely retrieves the radioactive source.
To simplify this process, the Bravos afterloader features a touch screen control that provides easy access to patient treatment data, eliminating the need for the radiology technician to leave the room in order to retrieve patient and treatment information. To facilitate execution, light emitting diode (LED) green, red, and yellow lights guide clinicians instinctively through the connection process of the transfer guide tubes. The green lights signal a proper connection, while the yellow and red lights warn that there are areas in need of correction.
To help increase efficiency of the treatment process, Bravos also features a customizable pre-treatment checklist on the touchscreen. Like surgical procedures, the customizable checklist allows the clinician to set a review process, including a time-out for patient safety, and e-signatures for speed and accuracy. The Bravos afterloader system, which has been received both U.S. Food and Drug Administration (FDA) and European Union CE marking, integrates with Varian's BrachyVision for treatment planning, and also offers interoperability with the Varian ARIA oncology information system.
“After spending time in clinics around the world talking with the treatment teams, we saw the opportunity to create a system that is easy to use and creates greater efficiencies, allowing clinicians to spend more time with the patient,” said Ed Vertatschitsch, vice president of global portfolio solutions at Varian. “Bravos is a big step forward for brachytherapy treatments, and we will continue to collaborate with our partners in achieving new victories against cancer.”
Latest Nuclear Medicine News
- New Imaging Technique Monitors Inflammation Disorders without Radiation Exposure
- New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access
- New Radiotheranostic System Detects and Treats Ovarian Cancer Noninvasively
- AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging
- Early 30-Minute Dynamic FDG-PET Acquisition Could Halve Lung Scan Times
- New Method for Triggering and Imaging Seizures to Help Guide Epilepsy Surgery
- Radioguided Surgery Accurately Detects and Removes Metastatic Lymph Nodes in Prostate Cancer Patients
- New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear
- Novel PET Tracer Enhances Lesion Detection in Medullary Thyroid Cancer
- Targeted Therapy Delivers Radiation Directly To Cells in Hard-To-Treat Cancers
- New PET Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Algorithm Predicts Prostate Cancer Recurrence in Patients Treated by Radiation Therapy
- Novel PET Imaging Tracer Noninvasively Identifies Cancer Gene Mutation for More Precise Diagnosis
- Ultrafast Laser Technology to Improve Cancer Treatment
- Low-Dose Radiation Therapy Demonstrates Potential for Treatment of Heart Failure
- New PET Radiotracer Aids Early, Noninvasive Detection of Inflammatory Bowel Disease